JAK2 and myeloproliferative disorder: Notably, high PD-L1 expression in monocytes has also been reported in non-Philadelphia chromosome myeloproliferative neoplasms with a JAK2 V617F mutation via STAT3/STAT5-dependent transcriptional induction51.